跳至主要内容
临床试验/RBR-2yvgyf
RBR-2yvgyf进行中(未招募)未知

A prospective randomized study on the effect of oesophageal temperature monitoring on the incidence of esophageal lesions after left atrial ablation for the treatment of atrial fibrillation.

Hospital das Clínicas da Faculdade de Medicina da USP0 个研究点开始时间: 2018年9月5日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 75Y(—)

入选标准

  • Patients with paroxysmal or persistent AF, diagnosed by electrocardiogram, 24-hour Holter, or monitors of implantable or non-implantable events, with at least one episode of AF up to 12 months before the procedure. Patients should be willing and able to sign an informed consent form, and to undergo all procedures described in both the study protocol and the consent form.

排除标准

  • Atrial thrombus in the left atrium; history of AF ablation; history of cardiac surgery; contraindication to anticoagulation; permanent AF; New York Heart Association functional class III or IV; stroke in the last 3 months; pregnancy, history blood clotting abnormalities; previous esophageal surgery; or advanced chronic kidney disease (creatinine > 2.5 mg/dl).

研究者

发起方
Hospital das Clínicas da Faculdade de Medicina da USP

相似试验